Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-04-29 Purchase |
2022-05-03 5:49 pm |
Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director 10% Owner |
2,118,644 | $2.36 | $5,000,000 | 4,295,055 (Indirect) |
View |
2020-12-30 Purchase |
2021-01-04 6:02 pm |
Gritstone Oncology Inc. | GRTS | Woiwode Thomas Director |
1,347,709 | $3.71 | $5,000,000 | 4,450,638 (Indirect) |
View |
2020-10-20 Purchase |
2020-10-20 5:00 pm |
Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director |
200,000 | $15 | $3,000,000 | 862,444 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-05-25 Option Award |
2023-05-26 4:38 pm |
N/A 2033-05-24 |
Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner |
24,000 | $0 | 24,000 (Direct) |
View |
2022-06-23 Option Award |
2022-06-27 4:14 pm |
N/A 2032-06-23 |
Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-17 Option Award |
2022-06-22 4:13 pm |
N/A 2032-06-16 |
Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director |
3,500 | $0 | 3,500 (Direct) |
View |
2022-05-26 Option Award |
2022-05-31 4:33 pm |
N/A 2032-05-25 |
Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner |
24,000 | $0 | 24,000 (Direct) |
View |
2021-07-01 Option Award(A) |
2021-09-20 8:13 pm |
N/A 2031-06-30 |
Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director |
6,635 | $0 | 6,635 (Direct) |
View |
2021-08-25 Other |
2021-08-27 5:49 pm |
N/A N/A |
Gritstone bio Inc. | GRTS | Woiwode Thomas Director |
458,152 | $0 | 3,574,489 (Indirect) |
View |
2021-07-01 Option Award |
2021-07-06 6:01 pm |
N/A 2031-06-30 |
Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director 10% Owner |
6,635 | $0 | 6,635 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 9:54 pm |
N/A N/A |
Millendo Therapeutics Inc. | TPST | Woiwode Thomas Director 10% Owner |
2,176,411 | $0 | 7,377 (Indirect) |
View |
2021-06-17 Option Award |
2021-06-17 5:14 pm |
N/A 2031-06-17 |
Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-11 Other |
2021-06-15 4:43 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director |
506,307 | $0 | 1,391,305 (Indirect) |
View |
2021-05-27 Option Award |
2021-05-28 6:06 pm |
N/A 2031-05-26 |
Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner |
16,918 | $0 | 16,918 (Direct) |
View |
2021-05-12 Option Award |
2021-05-14 8:05 pm |
N/A 2031-05-11 |
Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director |
40,000 | $0 | 40,000 (Direct) |
View |
2021-04-26 Other |
2021-04-28 5:00 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director |
506,310 | $0 | 1,389,085 (Indirect) |
View |
2020-12-14 Other |
2020-12-16 5:10 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director |
12,783 | $0 | 31,605 (Direct) |
View |
2020-10-20 Conversion |
2020-10-20 5:00 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director |
3,092,339 | $0 | 862,444 (Indirect) |
View |
Ownership |
2020-10-15 5:17 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director |
0 | $0 | 3,092,339 (Indirect) |
View |
2020-06-23 Option Award |
2020-06-25 5:45 pm |
N/A 2030-06-22 |
Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director |
30,000 | $0 | 30,000 (Direct) |
View |
2020-06-18 Option Award |
2020-06-22 5:40 pm |
N/A 2030-06-18 |
Gritstone Oncology Inc. | GRTS | Woiwode Thomas Director 10% Owner |
12,500 | $0 | 12,500 (Direct) |
View |